Dr. Ken Kongoji, Director of Kongoji Clinic

Dr. Ken Kongoji is the director of Kongoji Clinic with 26 years of extensive experience. He specializes in internal medicine, cardiology, and lifestyle diseases, and contributes to regional healthcare.

Extensive Experience and Expertise

With extensive experience gained from working in university hospitals and a regional medical institution, Dr. Kongoji possesses specialized knowledge and skills in a wide range of fields, including internal medicine, cardiology, lifestyle diseases, general internal medicine, minor trauma, dermatology, and pediatric vaccinations. He provides patient-centered care, tailoring his approach to each individual's unique needs.

Community-Based Healthcare

Committed to providing community-based healthcare, Dr. Kongoji is dedicated to safeguarding the health of local residents. He prioritizes patient communication, ensuring thorough examinations and clear explanations. Additionally, he contributes to establishing a seamless healthcare system by collaborating with Kyorin University Hospital.

Professional history
  • Assistant Professor, Department of Cardiology, St. Marianna University School of Medicine, Affiliated Hospital
  • Lecturer, Department of Internal Medicine (Cardiology), St. Marianna University School of Medicine
  • Lecturer, Department of Internal Medicine II, Division of Cardiology, Kyorin University School of Medicine
  • Associate Professor, Department of Cardiology, Kyorin University School of Medicine
  • April 22, 2022: Establishment of Kongoji Internal Medicine Clinic
Certifications and Awards
  • Japanese Society of Internal Medicine Certified Specialist
    This certification recognizes Dr. Kongoji's expertise in the field of internal medicine, demonstrating his comprehensive knowledge and skills in diagnosing, treating, and preventing non-surgical diseases of the internal organs.
  • Japanese Society of Cardiology Certified Specialist
    This certification attests to Dr. Kongoji's specialized proficiency in cardiology, highlighting his ability to handle complex cardiovascular conditions and provide high-quality care for patients with heart and blood vessel diseases.
  • Japanese Society for Cardiovascular Intervention Specialist
    This certification confirms Dr. Kongoji's expertise in performing minimally invasive procedures to treat cardiovascular diseases, such as angioplasty and stenting.
  • Japanese Society of Cardiovascular Endoscopy Gold Medal Award
    This prestigious award recognizes Dr. Kongoji's outstanding contributions to the field of cardiovascular endoscopy, a specialized technique used to diagnose and treat heart and vascular diseases using minimally invasive procedures.

Ainprose treatment

Ainprose (:anti-inflammatory products from stem cell) contains over 2,000 types of physiologically active substances, including endogenous bio-nanoparticles, which are believed to promote tissue regeneration by influencing cells. Expectations for its effectiveness of this therapy are high.

Expected Benefits of Ainprose

Vascular regeneration and angiogenesis.
Collateral angiogenesis for interrupted blood circulation due to atherosclerosis.
Nerve cell repair and regeneration.
Repair of peripheral nerves.
Anti-inflammation effects.
Promotes healing of damaged areas (injuries and inflammations) and reduces pain.
Anti-oxidant effects.
Recovery from fatigue, prevention of lifestyle diseases.
Immune system regulation.
Improvement in allergies and sensitivities.
Cosmetic Effects.
Anti-wrinkle and sagging treatment with tissue repairing.

Symptoms observed with the use of Ainprose in adjunctive therapy.

Bone, Muscle, Joint

  • Gout
  • Hernia
  • General stiffness
  • Frozen shoulders
  • Strained back
  • Bone fractures
  • Torn muscles
  • Heberden's nodes
  • Wrist tendonitis

Systemic symptoms

  • Headaches
  • Brain fog
  • Fatigue
  • Dizziness
  • Insomnia / night sweats
  • Chronic pain
  • Rheumatic diseases
  • Promote wound healing
  • Improve post-op after effects
  • Poor immunity
  • Swelling
  • Hangovers

Neurological symptoms

  • Numbness
  • Motor paralysis
  • Sensory abnormalities
  • Diabetic neuropathy
  • Dementia

Vascular symptoms

  • Arrhythmia
  • Peripheral circulation disorders
  • Arteriosclerosis
  • Myocardial infarction
  • Cerebral infraction

Liver pancreas symptoms

  • Dyslipidemia
  • High blood sugar

Respiratory symptoms

  • Pneumonia
  • Asthma

Vision symptoms

  • Eye strain
  • Impaired vision
  • Presbyopia
  • Floaters
  • Diabetic retinopathy

Urological symptoms

  • Frequent urination
  • Urinary incontinence
  • Erectile dysfunction (ED)

Skin

  • Rough skin
  • Vitiligo
  • Rashes
  • Burn scars

Gynecological symptoms

  • Infertility
  • Menopausal disorder
EGFEGF (Epidermal Growth Factor) is composed of amino acids that promote the production of new cells, which can act on various cells to encourage growth of cells, regulate proliferation, and make repairs.
VEGFVEGF (Vascular Endothelial Growth Factor) plays a key role in angiogenesis and induce cell division and differentiation, which causes the formation of new blood vessels that branch off from existing ones.
TGF-βTGF-β (Transforming Growth Factor) regulates cell proliferation, growth, differentiation, and motility, playing key roles in the reconstruction, wound healing, and immunity of cellular tissues.
HGFHGF (Hepatocyte Growth Factor) promotes the proliferation of hepatocytes involved in the synthesis and storage of proteins, the conversion of carbohydrates, and the detoxification, denaturation, and elimination of cholesterol and xenobiotics.
KGFKGF (Keratinocyte Growth Factor) is mitogenic ( induce cell division) with angiogenesis and wound healing effects, which assist in the production of keratin, an essential ingredient the formation of hair and skin.
IGFIGF (Insulin Growth Factor) is produced by growth hormone which is secreted in large quantities during puberty. They function in a variety of ways, including the promotion of cell proliferation/differentiation, and protein assimilation.
PDGFPDGF (Platelet-Derived Growth Factor) is produced by various cells such as epithelial and endothelial cells. They are involved in regulating the migration and proliferation of mesenchymal cells, which helps promote the growth and regeneration of damaged tissues.
FGFFGF (Fibroblast Growth Factor) is involved in angiogenesis and wound healing. They play key roles in the proliferation and differentiation of wide range of cells and tissues.
IL-7IL-7 (Interleukin-7) is bioactive substances that promote cell proliferation, and is keys to the survival, proliferation and maturation of cells.
GM-CSFGM-CSF (Granulocyte-Monocyte Colony-Stimulating Factor) promotes cell survival and activation. They are hematopoietic growth factors that promote the differentiation into pluripotent hematopoietic stem cells and function as immunoregulatory factors.
EPOEPO (Erythropoietin) is mainly produced in the kidneys, and are one of the hematopoietic factors that promote the production of red blood cells.
TSG-6TSG-6 (Anti-Inflammatory Factor) is gaining attention for suppressing inflammation, and as a treatment for arteriosclerosis.
TPOTPO (Thrombopoietin) is involved in the proliferation and differentiation of pro-platelets, and are considered to be key factors in the production of hematopoietic cells.
TIMPTIMP (Tissue Inhibitor of Metalloproteinase) inhabits the degradation of tissue collagen and elastin by MMPs, and helps prevent fibrosis.

Prices

Those who do NOT have a Japanese health insurance.

AINPROS® 30ml: 1 treatment
Intravenous infusion
671,000 JPY (including tax)
AINPROS® 30ml: 3 treatments
Intravenous infusion
+ [Re:A set of 4 cosmetics]
+ [NMN supplement]
2,013,000 JPY (including tax)
AINPROS® 30ml: 6treatments (+1)
Intravenous infusion
+ [Re:A set of 4 cosmetics]
+ [NMN supplement]
4,026,000 JPY (including tax)
AINPROS® 10ml: 1 treatment
Intravenous infusion
308,000 JPY (including tax)
AINPROS® 5ml: 1 treatment
Intra-articular injection
170,500 JPY (including tax)
AINPROS® treatment: 1 body part
Intra-articular injection
134,200 JPY (including tax)
AINPROS® 2ml
Ultrasonic Penetration
86,900 JPY (including tax)
AINPROS® 1ml
Ultrasonic Penetration
64,900 JPY (including tax)

※If you receive consultation without treatment, a consultation fee will be charged. ( visiting fee/¥16,600 + consultation fee per additional 15min/¥5,500)
※One of the risks associated with this therapy is that the administration of the stem cell culture supernatant may cause side effects such as temporary allergies.
※Stem cell culture supernatant is not a pharmaceutical product approved under the PMD Act.
※In Japan and other countries, there is no definitive information on the potential for serious risks associated with stem cell culture supernatant.
※There is no other approved pharmaceutical product in Japan with the same ingredients and functions as stem cell culture supernatant.

Clinic Information

Name of Medical InstitutionKONGOJI CLINIC
AddressBRANCH Chofu 3F 
7-47-1 Jindaiji Higashi-cho Chofu-shi, Tokyo 182-0012 Japan
Nearest StationAccess by Odakyu Bus:
From "Mitaka City Hall Mae": 2-minute walk.
From "Kami Renjyaku 8-chome": 1-minute walk.

Access by Keio Bus:
Take the bus from Chofu Station to BRANCH Chofu, or
From the "Kokenmae" bus stop, it's a 2-minute walk.

You can see the directions here and here.
Operation Hours9:00-12:00 / 14:00-18:00
Saturday 9:00-13:00
Closed: Thursdays, Sundays, and National Holidays
Websitehttps://kongoji-cl.com/